Search

Syndax Pharmaceuticals Inc

Отворен

СекторЗдравеопазване

24.65 8.83

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

22.66

Максимум

24.39

Ключови измерители

By Trading Economics

Приходи

25M

-43M

Продажби

-3.6M

65M

EPS

-0.48

Марж на печалбата

-65.788

Служители

298

EBITDA

-16M

-31M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+64.76% upside

Дивиденти

By Acuity

Следващи печалби

3.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

104M

2B

Предишно отваряне

15.82

Предишно затваряне

24.65

Настроения в новините

By Acuity

20%

80%

60 / 342 Класиране в Healthcare

Syndax Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.07.2026 г., 23:51 ч. UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7.07.2026 г., 23:43 ч. UTC

Social Media
News

Apple Inc. shares rose in after-hours trading, bolstered by a significant gain in a call option and an extended partnership with Broadcom through 2031.

7.07.2026 г., 23:41 ч. UTC

News

Concerns over Middle East tensions and rising oil prices support gains in iShares 7-10 Year Treasury Bond ETF during after-hours trading.

7.07.2026 г., 23:41 ч. UTC

Social Media
Correlated Moves
News

NVIDIA shares are lower in after-market trading as Michael Burry initiates short positions, citing concerns over reduced AI spending among businesses.

7.07.2026 г., 23:41 ч. UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is higher in after-market trading, supported by gains from key holdings despite broader market pressures and geopolitical tensions.

7.07.2026 г., 23:41 ч. UTC

ETF Constituents
Social Media
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in Invesco QQQ Trust during after-market hours, reflecting broader market concerns.

7.07.2026 г., 23:36 ч. UTC

ETF Constituents
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in the Vanguard Growth ETF during after-market hours.

7.07.2026 г., 23:21 ч. UTC

Social Media
News

Meta Platforms Inc. has gained after launching its Muse Image generator, enhancing user engagement despite facing $1.4 trillion in legal challenges.

7.07.2026 г., 23:06 ч. UTC

News

Geopolitical tensions rise after U.S. strikes on Iran, while the Reserve Bank of New Zealand is set to announce a rate hike. The ETF traded roughly flat in after-market hours.

7.07.2026 г., 23:06 ч. UTC

News

The United States Oil Fund LP is trading higher after military strikes against Iran escalated tensions, contributing to gains in WTI crude prices above $72.50.

7.07.2026 г., 23:06 ч. UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market trading amid broader market declines and concerns over chip stocks following Samsung's earnings report.

7.07.2026 г., 23:02 ч. UTC

Correlated Moves
News

Silver is lower in after-market hours, reflecting declines since Tuesday's close amid rising tensions from U.S. military actions and expectations of a New Zealand rate hike.

7.07.2026 г., 23:01 ч. UTC

ETF Constituents
Macro News
News

The Industrial Select Sector SPDR Fund declined in after-market hours amid geopolitical tensions and a hawkish Fed stance, impacting operating margins in the industrial sector.

7.07.2026 г., 23:01 ч. UTC

Social Media
News

T-Mobile US Inc. appointed Chris Sambar as Chief Enterprise Officer, effective by October 14, 2026, and shares traded higher in after-market hours.

7.07.2026 г., 22:51 ч. UTC

News

PayPal shares are lower in after-market hours following Barclays' Underweight rating and price target of $42.00, amid broader market weakness and geopolitical tensions.

7.07.2026 г., 20:07 ч. UTC

News
Correlated Moves

Bitcoin declines amid geopolitical tensions following missile attacks in the Strait of Hormuz. Regulatory approval for Bitcoin Suisse in the UAE adds complexity to investor sentiment.

7.07.2026 г., 20:07 ч. UTC

Correlated Moves
News

Bitcoin is lower today amid rising geopolitical tensions and concerns over oil supply disruptions. Ethereum's decline may also influence Bitcoin's price movement.

7.07.2026 г., 20:06 ч. UTC

Social Media
News
Correlated Moves

Synopsys Inc. is discontinuing its manufacturing process control software for semiconductor makers, shifting focus to AI design offerings. Shares are trading lower today.

7.07.2026 г., 20:06 ч. UTC

Social Media
News

Amazon.com Inc shares are higher following a $25 billion bond sale to fund AI infrastructure, attracting $62 billion in demand and receiving an 'AA-' rating from Fitch.

7.07.2026 г., 20:06 ч. UTC

News
Social Media
Correlated Moves

Broadcom Inc shares are lower today following a downgrade to Hold by Erste Group, amid broader declines in the semiconductor sector.

7.07.2026 г., 20:06 ч. UTC

News
Correlated Moves

Ethereum is trading lower following a suspicious transaction linked to an exploiter, resulting in estimated losses of around $6 million.

7.07.2026 г., 20:04 ч. UTC

News
Social Media

Tesla Inc. shares are lower today amid criticism of CEO Elon Musk's governance linked to negative brand perception, despite RBC raising its price target to $500.

7.07.2026 г., 20:03 ч. UTC

Social Media
News

Fiserv is in talks to sell its debit card network for about $15 billion. Shares are trading lower amid market volatility despite earlier gains.

7.07.2026 г., 20:03 ч. UTC

News
Correlated Moves

Analog Devices has completed its acquisition of Empower Semiconductor to enhance AI capabilities. Shares are declining amid broader market pressures affecting the semiconductor sector.

7.07.2026 г., 20:02 ч. UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

7.07.2026 г., 19:52 ч. UTC

Social Media
News
Correlated Moves

Alphabet Inc. is under investigation in Nigeria for alleged anti-competitive practices, contributing to a decline in shares during Tuesday's session.

7.07.2026 г., 19:46 ч. UTC

News
Social Media
Correlated Moves

Costco faces scrutiny from a class-action lawsuit alleging toxic heavy metals in its protein products, contributing to shares trading lower since Monday's close.

7.07.2026 г., 19:44 ч. UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

7.07.2026 г., 19:36 ч. UTC

News
Correlated Moves

Ethereum is trading lower amid a suspicious transaction linked to an exploiter, resulting in estimated losses of $6 million and concerns over price manipulation.

7.07.2026 г., 19:36 ч. UTC

News
Social Media

Vertex Pharmaceuticals shares are lower today following its $10 billion acquisition of Crinetics Pharmaceuticals, despite analyst support and price target increases.

Сравнение с други в отрасъла

Ценова промяна

Syndax Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

64.76% нагоре

12-месечна прогноза

Среден 36.38 USD  64.76%

Висок 46 USD

Нисък 29 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Syndax Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

9

Купи

0

Задържане

0

Продай

Настроение

By Acuity

60 / 342 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
help-icon Live chat